Newsletter | April 4, 2025

04.04.25 -- How To Get Ready For The Talent Migration Between Pharma And Biotech

NEW PODCAST EPISODE

Advancing Retinal Gene Therapy with Atsena Therapeutics' Dr. Kenji Fujita

On Cell & Gene: The Podcast, Erin Harris chats with Dr. Kenji Fujita, CMO of Atsena Therapeutics, about groundbreaking retinal gene therapy for X-linked retinoschisis (XLRS)—a rare genetic disease with no FDA-approved treatment. Discover how Atsena’s AAV vector technology aims to overcome gene delivery challenges and what the recent Fast Track designation means for patients. Listen now and subscribe so you never miss an episode.

FEATURED ARTICLE

How To Get Ready For The Talent Migration Between Pharma And Biotech

A looming patent cliff is driving Big Pharma reorganization. Executives making career moves must understand differences in Big Pharma and biotech culture and expectations to be successful.

INDUSTRY INSIGHTS

Gene, Cell, And RNA Therapy Landscape Continues To Thrive

The horizons of molecular medicine continued to expand in the Q4 2024, with pre-registration gene therapy programs up 83% from the third quarter.

The Past, Present, And Future Of Mobile Visits In DCTs

From pandemic-driven adoption to a new era of patient-centric research, experts share insights and strategies for the future of decentralized clinical trials (DCTs).

Tips For Better eCOA Experiences From Medable's Patient Caregiver Network

Hear from patients and caregivers across various therapeutic areas as they offer tips on improving the clinical trial experience.

Why Taxes Jeopardize Clinical Trial Access And How You Can Help

Learn the history behind the Harley Jacobsen Act (H.R. 7418), a bill introduced to Congress in 2024 that seeks to exempt all clinical trial payments from taxation.

Collaboration, Local Knowledge Key To The Nordic Pharmaceutical Market

Companies looking to tap into the Nordic pharmaceutical market must recognize the unique blend of shared values and individual regulatory landscapes that define its unique approach to healthcare.

How To Unlock The Secret To Repeatable, Scalable Low Turnover

Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.